Michael Gold to Papillomavirus Vaccines
This is a "connection" page, showing publications Michael Gold has written about Papillomavirus Vaccines.
Connection Strength
0.181
-
Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine. Pediatr Infect Dis J. 2010 Feb; 29(2):95-101.
Score: 0.082
-
Age-appropriate use of human papillomavirus vaccines in the U.S. Gynecol Oncol. 2009 Aug; 114(2):365-9.
Score: 0.079
-
Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer. 2009 Nov 01; 125(9):2151-8.
Score: 0.020